Plasma Proteins
Therapeutic Potential of Novel Plasma Protein Production Technology
David Holliday, DMS; Mark Krause
Evolve Biologics
PAP-Q3-20-CL-029Sep 29, 2020
FDA Approval
Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies
Grifols
PR-M07-19-NI-018Jul 09, 2019